+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets



Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets



Biochemical Journal 243(3): 815-819



High concentrations of neomycin (2-10 mM) inhibited aggregation, but not shape change, of intact platelets by collagen, ADP and the Ca2+ ionophore, A23187, the last two studies being carried out in the presence of the cyclo-oxygenase inhibitor indomethacin. In contrast, over the same range of concentrations neomycin inhibited both aggregation and shape change induced by thrombin. Under these conditions activation of platelets by collagen and by thrombin, but not by A23187 or by ADP, is believed to be dependent on the hydrolysis of membrane inositol phospholipids. These data therefore suggest that the inhibitory action of neomycin on intact platelets is not related to its previously reported inhibitory effect on phosphoinositide metabolism. The selective inhibition of thrombin-induced shape change indicates a second site of action of neomycin on intact platelets. On platelets rendered semi-permeable with saponin, neomycin and a second aminoglycoside antibiotic, streptomycin (each 0.06-2 mM), stimulated secretion and aggregation responses. These effects were inhibited by indomethacin and by EGTA. Activation of semi-permeabilized platelets by neomycin is associated with the formation of inositol phosphates and phosphatidic acid, indicating activation by phospholipase C. This effect is also inhibited by indomethacin, implying that it is secondary to the formation of prostaglandins and endoperoxides. These results are discussed in the context of the use of neomycin as a selective inhibitor of polyphosphoinositide metabolism.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040780197

Download citation: RISBibTeXText

PMID: 3663101

DOI: 10.1042/bj2430815


Related references

Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin. Journal of Biological Chemistry 260(11): 7078-7083, 1985

Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets. Febs Letters 264(1): 33-36, 1990

Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of -thrombin to intact human platelets. Biochemical Journal 273(1): 241-243, 1991

Neomycin does not interfere with the inositol phospholipid metabolism, but blocks binding of alpha-thrombin to intact human platelets. Biochemical Journal 273(Pt 1): 241-243, 1991

Inositol 1,4,5-trisphosphate-induced calcium release in permeabilized platelets is coupled to hydrolysis of inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate. Biochemical and Biophysical Research Communications 195(1): 19-24, 1993

Neomycin stimulates secretion and aggregation in saponin permeabilized human platelets. British Journal of Pharmacology 89(Suppl.): 854P, 1986

Myo-Inositol 1,4,5-trisphosphate stimulates protein phosphorylation in saponin-permeabilized human platelets. Proceedings of the National Academy of Sciences of the United States of America 81(23): 7431-7435, 1984

Inositol 1,4,5-trisphosphate induces aggregation and release of 5-hydroxytryptamine from saponin-permeabilized human platelets. Journal of Biological Chemistry 261(12): 5368-5372, 1986

Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets. Biochemical Journal 233(3): 707-718, 1986

Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets. Biochemical Medicine and Metabolic Biology 45(2): 171-180, 1991

A radioreceptor assay for mass measurement of inositol (1,4,5)-trisphosphate using saponin-permeabilized outdated human platelets. Analytical Biochemistry 256(1): 117-121, 1998

Effect of adenylate cyclase activation on t cell receptor tcr or guanosine 5 o 3 thiotriphosphate gtp gamma s stimulated inositol phospholipid inspl hydrolysis in intact or permeabilized murine t helper th lymphocytes. Journal of Cellular Biochemistry Suppl. (14 Part C): 144, 1990

Dephosphorylation of inositol 1 3 4 5 tetrakisphosphate to inositol 1 4 5 trisphosphate in permeabilized platelets incubated with potassium chloride. FASEB Journal 3(3): A370, 1989

Activation of permeabilized platelets by inositol-1,4,5-trisphosphate. Thrombosis Research 40(4): 499-509, 1985

Aggregation of permeabilized platelets in response in inositol trisphosphate. Pediatric Researchpart 2: 263a, 1985